In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Hannover, Tierärztliche Hochschule Hannover, Dissertation, 2017
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Bibliothek der Tierärztlichen Hochschule Hannover
- (when)
-
2017
- Creator
-
Granitzny, Anne
- URN
-
urn:nbn:de:gbv:95-110521
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Granitzny, Anne
- Bibliothek der Tierärztlichen Hochschule Hannover
Time of origin
- 2017
Other Objects (12)
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations